Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.77 HKD | -6.35% | -2.21% | -50.70% |
04-30 | Transcenta Holding Limited Announces Board and Nomination Changes | CI |
04-09 | Transcenta Partners with Agilent to Develop Claudin18.2 Companion Diagnostic | MT |
Business Summary
Number of employees: 215
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oncology and Non-oncology Therapeutics
100.0
%
| 118 | 100.0 % | 60 | 100.0 % | -49.78% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 118 | 100.0 % | 60 | 100.0 % | -49.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Xue Ming Qian
FOU | Founder | 57 | 31/07/10 |
Xiao Lu Weng
DFI | Director of Finance/CFO | 47 | 16/12/21 |
Caroline Germa
CTO | Chief Tech/Sci/R&D Officer | 52 | 07/08/22 |
Charlie Qi
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/20 |
Yi Gu
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/01/19 |
Ming Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | - |
Chief Tech/Sci/R&D Officer | 61 | 30/09/16 | |
Feng Ye
COO | Chief Operating Officer | 57 | 31/12/15 |
Wei Wang
IRC | Investor Relations Contact | 41 | 20/03/22 |
Agnes Dai
HRO | Human Resources Officer | - | 31/01/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Ning Zhao
FOU | Founder | 53 | 30/11/18 |
Xue Ming Qian
FOU | Founder | 57 | 31/07/10 |
Jia Song Tang
BRD | Director/Board Member | 50 | 13/09/21 |
Zhi Hua Zhang
BRD | Director/Board Member | 43 | 13/09/21 |
Ming Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | - |
Kumar Srinivasan
BRD | Director/Board Member | 59 | 18/12/22 |
Xiao Lu Weng
DFI | Director of Finance/CFO | 47 | 16/12/21 |
Wei Chen
BRD | Director/Board Member | 57 | 22/08/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 436,375,375 | 391,491,827 ( 89.71 %) | 0 | 89.71 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.70% | 98.27M | |
+30.38% | 684B | |
+29.42% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.23% | 240B | |
+9.21% | 208B | |
-7.48% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 6628 Stock
- Company Transcenta Holding Limited